News

ModiQuest Research will be attending the PEGS conference, Boston, 1-5 May 2017

ModiQuest Research, a leading custom antibody generation and development company, will be attending the Protein engineering summit this May 1-5 in Boston. Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies is an important antibody engineering step … Continue reading

ModiQuest Research acquired ’Crédit d’Impôt Recherche’, CIR

We are pleased to announce that ModiQuest Research has acquired ’Crédit d’Impôt Recherche’ (CIR) accreditation from the French Ministry of Higher Education and Research. The French R&D tax credit initiative gives eligible research-based French companies, who are subject to corporate tax in France, the ability to claim significant tax reduction on costs generated in R&D … Continue reading

ModiQuest Research will be attending the AET conference, San Diego, 11-15 December 2016

ModiQuest Research will be attending the AET conference ModiQuest Research, a leading custom antibody generation and development company, will be attending the Antibody Engineering and Therapeutics conference this December 11-15 in San Diego. There is a substantial interest in high-quality, functional antibodies against membrane spanning proteins, especially those considered intractable targets. Generating antibodies against these targets … Continue reading

ModiQuest Research will be attending the Milner Therapeutic Symposium, November 17

The inaugural Milner Therapeutics Symposium, From Basic Research to Drugs in Patients, will be held on 17 November 2016 at St. Catharine’s College, Cambridge. The Milner Therapeutics Symposium is a one day event that will bring together world-leading scientists in cancer biology, neurobiology, immunology and regenerative medicine with top companies from the pharmaceutical and biotechnology … Continue reading

Upcoming Webinar: ModiQuest Research and AstraZeneca, MD Anderson Cancer Center, share their screening and profiling strategies using the iQue Screener Platform

Amongst other subjects this webinar will overview: How ModiQuest Research maximized their chances of finding therapeutic leads by implementing the iQue Screener platform, speaker Andrea Gorlani, Ph.D., scientist. For more information see: Webinar Intellicyt  

Citryll will present on Annual European Congress of Rheumatology EULAR 2016 London, UK, 8 – 11 June 2016

Citryll will present on Annual European Congress of Rheumatology EULAR 2016 London, UK, 8 – 11 June 2016 Renato Chirivi, Ph.D. Head Internal Therapeutic development will be presenting at the 10th international congress on Autoimmunity, Leipzig, Germany. The conference will be held from 6-10 April. We will be presenting the latest data on Citryll’s NETosis … Continue reading

ModiQuest Research will be attending the PEGS Boston, April 25-28

ModiQuest Research, a leading custom antibody generation and development company, will be attending the PEGS Summit conference this April 25-28 in Boston.   There is a substantial interest in high-quality antibodies against membrane spanning proteins. Generating antibodies against the native conformation of these intractable drug targets is very challenging, and crucial for therapeutic and diagnostic … Continue reading

ModiQuest Research and Sobi™ to Continue their Collaboration on Antibody Generation

March 16, 2016 – Oss, The Netherlands. ModiQuest Research BV, the Dutch antibody services company, today announced that it will continue its collaboration with Sobi™ aimed at the generation of novel monoclonal antibodies against Sobi target(s). During the new project, ModiQuest will screen their high class in-house phage display libraries, ModiPhageTM. Financials details of the … Continue reading

Citryll will present at 10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016

Citryll will present at 10th International Congress on Autoimmunity Renato Chirivi, Ph.D. Head Internal Therapeutic development will be presenting at the 10th international congress on Autoimmunity, Leipzig, Germany. The conference will be held from 6-10 April. We will be presenting the latest data on Citryll’s NETosis interfering therapeutic antibody, tACPA. An ideal opportunity to meet … Continue reading

Reduced prices : Save money on high quality antibodies

More than 40% reduction on ModiQuest products! ModiQuest permanently reduced the prices on its catalogue products: human anti-MMP-14 antibody (MQR2.701), human anti-resistin antibody (MQR2.801), mouse anti-phosphoserine antibody (MQR1.901) and mouse anti-acetylated antibody (MQR1.1001). Please visit our website, www.modiquestresearch.com, to look at our catalogue products or you can place your order directly via product inquiry New … Continue reading

shopping basket 0 items

Shopping Cart

0

Your shopping cart is empty:

please visit the shop